SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Completes Enrollment in Heart Attack Detection Pilot

Company will license its 3D ECG signal technology to established partners, moving beyond direct medi

Publication in JACC: Advances demonstrates that an algorithm combining the HeartBeam ECG device with

HC Wainwright & Co. analyst Yi Chen maintains HeartBeam (NASDAQ:BEAT) with a Buy and lowers t

Benchmark analyst Bill Sutherland maintains HeartBeam (NASDAQ:BEAT) with a Speculative Buy and lo

HeartBeam (NASDAQ:BEAT) reported quarterly losses of $(0.12) per share which beat the analyst consen

The study is being conducted at two leading hospitals in Belgrade, Serbia. The initiation of the pil

Leading concierge practice Atelier Health, led by physicians affiliated with Cedars-Sinai, will now

NN Inc. (NNBR) rose in pre-market trading after announcing expected sales growth and raising full-ye

B. Riley Securities analyst Anderson Schock initiates coverage on HeartBeam (NASDAQ:BEAT) with a

Wall Street analysts change outlook on top names. Check analyst ratings page for upgrades, downgrade

D. Boral Capital analyst Jason Kolbert initiates coverage on HeartBeam (NASDAQ:BEAT) with a Buy r

HC Wainwright & Co. analyst Yi Chen reiterates HeartBeam (NASDAQ:BEAT) with a Buy and maintai

HeartBeam (NASDAQ:BEAT) reported quarterly losses of $(0.14) per share which missed the analyst cons

HeartBeam shares are trading higher Tuesday following a partnership with Mount Sinai to accelerate n

HeartBeam, Inc. (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care by

HeartBeam, Inc. (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care by

Benchmark analyst Bill Sutherland upgrades HeartBeam (NASDAQ:BEAT) from Speculative Buy to Buy an

ORCL, SNPS, BEAT, PL, ADBE were among the stocks seen trending on Wednesday, Dec. 10, 2025.

HC Wainwright & Co. analyst Yi Chen maintains HeartBeam (NASDAQ:BEAT) with a Buy and raises t

HeartBeam shares rise after FDA clears its 12-lead ECG software, boosting plans for a 2026 launch an

HC Wainwright & Co. analyst Yi Chen initiates coverage on HeartBeam (NASDAQ:BEAT) with a Buy

HeartBeam shares jumped 40.75% in after-hours trading after the company outlined its regulatory stra

Immediately following the receipt of the NSE letter and through today, HeartBeam has been engaging w

Company engaging in multiple options for a constructive resolutionStrategy is underpinned by a clini